Molecular biology reports · 2026
Research progress on the roles and mechanisms of flavonoid monomers in liver diseases: a review.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Weijia, Chen Mi, Lu Chenxia, Li Li, Dai Shupeng, Zhang Shengnan
Аннотация
The liver, a vital metabolic organ with critical roles in detoxification, digestion, and metabolism, is highly susceptible to damage caused by the consumption of alcohol and drugs or infection of viruses. Persistent injury to the liver may progress to severe conditions. Flavonoid monomers, characterized by a fundamental 2-phenylchromone backbone, are a class of traditional Chinese medicine-derived natural polyphenolic compounds. These compounds can inhibit inflammation, oxidation, fibrosis, cancer, and diverse other pathological disorders pharmacologically, which are promising for the treatment of liver diseases. However, the specific mechanisms of flavonoid monomers in liver diseases remain unclear. Based on an extensive literature review, this work summarizes recent research advances on the mechanism of flavonoid monomers in liver diseases. This review is expected to provide novel insights that support the therapeutic application of flavonoid monomers in liver disease treatment.